Skip to content
Menu
  • Business areas
  • Responsibility
  • News
  • Who We Are
  • Career
  • Contact
Menu
  • Business areas
  • Responsibility
  • News
  • Who We Are
  • Career
  • Contact

The trusted partner. For better lives.

Experience

Services

Other business areas

Small molecules formulations

Liquid Pharmaceuticals based on sterile blow-fill-seal (BFS) technology and Nasal Spray. Sterile and aseptic development and fill & finish.

Nasal spray
Blow-fill-seal
Product development
Tech transfer
Controlled substances
Quality

Biologics

Curida Diatec is specialized on monoclonal antibodies production and conjugation. This service was added to Curida’s offering following the acquisition of Diatec in 2022.

Services
Experience
Products
Quality

Other services

We serve Norwegian pharmacies with raw materials and liquid products from Ås produksjonslab.

Raw material services
Special pharmaceuticals
Cosmetics and nutrition

Contact

Want to partner with us?

Contact us to learn more about our pharmaceutical development or manufacturing solutions. We look forward to discussing your next project with you! Our customers range from academic research, start-ups and early stage Biotech companies, to Big Pharma.

Small molecules formulations contact
 
Business Development Director Alvaro Lopez Guerao alvaro.lopez@curida.no
Curida Elverum Solbærvegen 5 2409 Elverum Norway +47 62 42 83 00
Biologics contact

 

Director, Curida, Biologics
Mira H. Børstad
mirab@diatec.com

Curida Diatec
Martin Linges vei 25
1364 Fornebu
Norway

Other services contact

 

Director, Ås produksjonslab
Ørjan L. Apeland
orjan.apeland@aasproduksjonslab.no

Customer service, raw materials
Mette Stenstad
mette.stenstad@curida.no

Ås Produksjonslab
Gamleveien 2
1434 Ås
Norway

post@aasproduksjonslab.no

LinkedIn

Privacy policy

© Curida 2024

  • Business areas
  • Responsibility
  • News
  • Who We Are
  • Career
  • Contact
  • Business areas
  • Responsibility
  • News
  • Who We Are
  • Career
  • Contact

This website uses cookies

Accept | Decline